FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill.

(From Hugin)

Corporate news announcement processed and transmitted by Hugin AS.

The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Exforge HCT combines in one pill a calcium channel blocker, angiotensin receptor blocker and diuretic (amlodipine, valsartan, hydrochlorothiazide)

In a clinical trial, Exforge HCT demonstrated significantly greater reductions in systolic and diastolic BP, compared to all dual combinations of its components[1]

Up to 85% of patients may need multiple medications to help control their blood pressure[2] and many need three or more[1]

Exforge HCT can help appropriate patients reach BP goals; offers convenience and potential cost savings by reducing up to three co-payments to one

Basel, 30 April, 2009 - The US Food and Drug Administration (FDA) has approved Exforge HCT, the only single pill to combine the three most prescribed high blood pressure treatments in their classes in the US[3]: the calcium channel blocker amlodipine, the angiotensin receptor blocker valsartan, and the diuretic hydrochlorothiazide.

Exforge HCT is an important new option for patients who have tried taking dual combinations of these classes of blood pressure medications without success.

"The majority of people with hypertension will require more than one medication to control their blood pressure and it's not uncommon for patients with severe …